Association of achieved dialysis dose with mortality in the Hemodialysis Study: An example of "dose-targeting bias"

被引:67
作者
Greene, T
Daugirdas, J
Depner, T
Allon, M
Beck, G
Chumlea, C
Delmez, J
Gotch, F
Kusek, JW
Levin, N
Owen, W
Schulman, G
Star, R
Toto, R
Eknoyan, G
机构
[1] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
[2] Univ Illinois, Sch Med, Chicago, IL USA
[3] Univ Calif Davis, Div Nephrol, Sacramento, CA 95817 USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] Wright State Univ, Boonshoft Sch Med, Dept Community Hlth, Dayton, OH 45435 USA
[6] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA
[7] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
[8] NIDDKD, NIH, Bethesda, MD 20892 USA
[9] Beth Israel Deaconess Med Ctr, Renal Res Inst, New York, NY 10003 USA
[10] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[11] Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA
[12] Univ Texas, SW Med Ctr, Dallas, TX 75230 USA
[13] Baylor Coll Med, Houston, TX 77030 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 11期
关键词
D O I
10.1681/ASN.2005030321
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In the intention-to-treat analysis of the Hemodialysis Study, all-cause mortality did not differ significantly between the high versus standard hemodialysis dose groups. The association of mortality with delivered dose within each of the two randomized treatment groups was examined, and implications for observational studies were considered. Time-dependent Cox regression was used to relate the relative risk (RR) for mortality to the running mean of the achieved equilibrated Kt/V (eKt/V) over the preceding 4 mo. eKt/V was categorized by quintiles within each dose group. Analyses were controlled for case-mix factors and baseline anthropometric volume. Within each randomized dose group, mortality was elevated markedly when achieved eKt/V was in the lowest quintile (RR, 1.93; 95% confidence interval [CI], 1.40 to 2.66; P < 0.0001 in the standard-dose group; RR, 2.04; 95% CI, 1.50 to 2.76; P < 0.0001 in the high-dose group; RR relative to the middle quintiles). The mortality rate in the lowest eKt/V quintile of the high-dose group was higher than in the full standard-dose group (RR, 1.59; 95% CI, 1.29 to 1.96; P < 0.0001). Each 0.1 eK/V unit below the group median was associated with a 58% higher mortality in the standard-dose group (P < 0.001) and a 37% higher mortality in the high-dose group (P < 0.001). The magnitude of these dose-mortality effects was seven- to 12-fold higher than the upper limit of the 95% CI from the intention-to-treat analysis. The effects were attenuated in lagged analyses but did not disappear. When dialysis dose is targeted closely, as under the controlled conditions of the Hemodialysis Study, patients with the lowest achieved dose relative to their target dose experience markedly increased mortality, to a degree that is not compatible with a biologic effect of dose. The possibility of similar (albeit smaller) biases should be considered when analyzing observational data sets relating mortality to achieved dose of dialysis.
引用
收藏
页码:3371 / 3380
页数:10
相关论文
共 48 条
  • [11] Depner TA., 1991, PRESCRIBING HEMODIAL
  • [12] Type of vascular access and mortality in US hemodialysis patients
    Dhingra, RK
    Young, EW
    Hulbert-Shearon, TE
    Leavey, SF
    Port, FK
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (04) : 1443 - 1451
  • [13] Diggle PJ., 2002, ANAL LONGITUDINAL DA
  • [14] The dangers of inferring treatment effects from observational data: a case study in HIV infection
    Dunn, D
    Babiker, A
    Hooker, M
    Darbyshire, J
    [J]. CONTROLLED CLINICAL TRIALS, 2002, 23 (02): : 106 - 110
  • [15] Eknoyan G, 1997, KIDNEY INT, V52, P1395
  • [16] Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan, G
    Beck, GJ
    Cheung, AK
    Daugirdas, JT
    Greene, T
    Kusek, JW
    Allon, M
    Bailey, J
    Delmez, JA
    Depner, TA
    Dwyer, JT
    Levey, AS
    Levin, NW
    Milford, E
    Ornt, DB
    Rocco, MV
    Schulman, G
    Schwab, SJ
    Teehan, BP
    Toto, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) : 2010 - 2019
  • [17] The hemodialysis (HEMO) study: Rationale for selection of interventions
    Eknoyan, G
    Levey, AS
    Beck, GJ
    Agodoa, LY
    Daugirdas, JT
    Kusek, JW
    Levin, NW
    Schulman, G
    [J]. SEMINARS IN DIALYSIS, 1996, 9 (01) : 24 - 33
  • [18] Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
    Frangakis, CE
    Rubin, DB
    [J]. BIOMETRIKA, 1999, 86 (02) : 365 - 379
  • [19] Design and statistical issues of the Hemodialysis (HEMO) Study
    Greene, T
    Beck, GJ
    Gassman, JJ
    Gotch, FA
    Kusek, JW
    Levey, AS
    Levin, NW
    Schulman, G
    Eknoyan, G
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (05): : 502 - 525
  • [20] RECENT DEVELOPMENTS AND FUTURE-ISSUES IN THE USE OF HEALTH-STATUS ASSESSMENT MEASURES IN CLINICAL SETTINGS
    GREENFIELD, S
    NELSON, EC
    [J]. MEDICAL CARE, 1992, 30 (05) : MS23 - MS41